secwatch.observer — SEC 8-K summary
======================================

Issuer:     ALNYLAM PHARMACEUTICALS, INC. (ALNY)
CIK:        0001178670
Form:       8-K
Filed at:   2023-05-23T23:59:59+00:00
Accession:  0001193125-23-151845
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alnylam shareholders re-elect four Class I directors, approve say-on-pay, ratify auditor
--------------------------------------------------------------------------------

- Michael Bonney re-elected with 101.9M for vs 11.8M against; Yvonne Greenstreet 112.4M for vs 1.3M against.
- Phillip Sharp re-elected 101.4M for vs 12.3M against; Elliott Sigal 110.1M for vs 3.6M against.
- Say-on-pay approved: 109.7M for, 4.0M against; 1-year frequency recommended with 113.5M votes.
- PricewaterhouseCoopers ratified as independent auditor for FY2023: 116.1M for, 1.8M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1178670/000119312523151845/0001193125-23-151845-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1178670/000119312523151845/d689062d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-151845

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer